Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance

Project Information

PrIMAVeRa

Grant agreement ID: 101034420

DOI

10.3030/101034420

EC signature date 9 November 2021

Start date 1 November 2021

End date 31 October 2026

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost

€ 9 250 000,00

EU contribution

€ 6 500 000,00

Coordinated by

EUROPEAN VACCINE INITIATIVE E.V
Germany